Zenith Epigenetics

don't forget this nugget:

Part of the objective is to add value and show Proof of Concept early. That will allow us to proceed with some of the pharma discussions we’ve been having.

taken from a larger response of:

A: 5 or 6 sites in US with UCSF and MSKCC being the primary ones. Also some sites from PCCTC. The trials will start this quarter. These patients are very sick. Part of the objective is to add value and show Proof of Concept early. That will allow us to proceed with some of the pharma discussions we’ve been having.